{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:15:07Z","timestamp":1793823307694,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["329"],"award-info":[{"award-number":["329"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26718-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:24:40Z","timestamp":1764325480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3582-067X","authenticated-orcid":false,"given":"Piotr","family":"Szkodziak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Szkodziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Trzeciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Mlynarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Paszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"26718_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis, E. & Dunaif, A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981\u20131030 (2012).","journal-title":"Endocr. Rev."},{"key":"26718_CR2","doi-asserted-by":"publisher","unstructured":"Armanini, D., Boscaro, M., Bordin, L. & Sabbadin, C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: Focus on insulin resistance, inflammation, and hyperandrogenism. Int. J. Mol .Sci. 23(8), 4110. https:\/\/doi.org\/10.3390\/ijms23084110 (2022).","DOI":"10.3390\/ijms23084110"},{"key":"26718_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","volume":"77","author":"CM Burt Solorzano","year":"2012","unstructured":"Burt Solorzano, C. M. et al. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 77, 332\u2013337 (2012).","journal-title":"Steroids"},{"key":"26718_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1210\/endrev\/bnad023","volume":"45","author":"B Patel","year":"2024","unstructured":"Patel, B. et al. The emerging therapeutic potential of Kisspeptin and neurokinin B. Endocr. Rev. 45, 30\u201368 (2024).","journal-title":"Endocr. Rev."},{"key":"26718_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/endo-109-2-376","volume":"109","author":"L Wildt","year":"1981","unstructured":"Wildt, L. et al. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 109, 376\u2013385 (1981).","journal-title":"Endocrinology"},{"key":"26718_CR6","doi-asserted-by":"publisher","first-page":"e12487","DOI":"10.1002\/rmb2.12487","volume":"21","author":"M Harada","year":"2022","unstructured":"Harada, M. Pathophysiology of polycystic ovary syndrome revisited: current Understanding and perspectives regarding future research. Reprod. Med. Biol. 21, e12487 (2022).","journal-title":"Reprod. Med. Biol."},{"key":"26718_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/09513590.2020.1813274","volume":"37","author":"P Sharma","year":"2021","unstructured":"Sharma, P., Kaur, M. & Khetarpal, P. CYP19 gene rs2414096 variant and differential genetic risk of polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol. Endocrinol. 37, 126\u2013131 (2021).","journal-title":"Gynecol. Endocrinol."},{"key":"26718_CR8","doi-asserted-by":"publisher","unstructured":"Hegde, P. et al. Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome. J. Genet. Eng. Biotechnol. 21(1), 87. https:\/\/doi.org\/10.1186\/s43141-023-00540-7 (2023).","DOI":"10.1186\/s43141-023-00540-7"},{"key":"26718_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/09513590.2020.1822803","volume":"37","author":"N Munawar Lone","year":"2021","unstructured":"Munawar Lone, N. et al. Association of the CYP17 and CYP19 gene polymorphisms in women with polycystic ovary syndrome from Punjab, Pakistan. Gynecol. Endocrinol. 37, 456\u2013461 (2021).","journal-title":"Gynecol. Endocrinol."},{"key":"26718_CR10","doi-asserted-by":"publisher","unstructured":"Ashraf, S. et al. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women. Sci. Rep. 11(1), 12942. https:\/\/doi.org\/10.1038\/s41598-021-92265-1 (2021).","DOI":"10.1038\/s41598-021-92265-1"},{"key":"26718_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2350-10-139","volume":"10","author":"JL Jin","year":"2009","unstructured":"Jin, J. L. et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med. Genet. 10, 139 (2009).","journal-title":"BMC Med. Genet."},{"key":"26718_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/obe.2007.0019","volume":"3","author":"S Sam","year":"2007","unstructured":"Sam, S. Obesity and polycystic ovary syndrome. Obes. Manag. 3, 69 (2007).","journal-title":"Obes. Manag"},{"key":"26718_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin, E. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Primers 10, 1\u201323 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"26718_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L. & Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37, 467 (2016).","journal-title":"Endocr. Rev."},{"key":"26718_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"BCJM Fauser","year":"2004","unstructured":"Fauser, B. C. J. M. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19\u201325 (2004).","journal-title":"Fertil. Steril."},{"key":"26718_CR16","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","volume":"93","author":"A Huang","year":"2010","unstructured":"Huang, A., Brennan, K. & Azziz, R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National institutes of health 1990 criteria. Fertil. Steril. 93, 1938\u20131941 (2010).","journal-title":"Fertil. Steril."},{"key":"26718_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456\u2013488 (2009).","journal-title":"Fertil. Steril."},{"key":"26718_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede, H. J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33, 1602\u20131618 (2018).","journal-title":"Hum. Reprod."},{"key":"26718_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/diagnostics13061113","volume":"13","author":"JP Christ","year":"2023","unstructured":"Christ, J. P. & Cedars, M. I. Current Guidelines for Diagnosing PCOS. Diagnostics 13, 1113. https:\/\/doi.org\/10.3390\/diagnostics13061113 (2023).","journal-title":"Diagnostics"},{"key":"26718_CR20","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. & Yildiz, B. O. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-Analysis. Hum. Reprod. 31, 2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218 (2016).","journal-title":"Hum. Reprod."},{"key":"26718_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz, R. Reproductive endocrinology and infertility: clinical expert series polycystic ovary syndrome. Obstet. Gynecol. 132, 321\u2013336 (2018).","journal-title":"Obstet. Gynecol."},{"key":"26718_CR22","doi-asserted-by":"publisher","unstructured":"Ezeh, U., Yildiz, B. O. & Azziz, R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 98(6), E1088\u2013E1096. https:\/\/doi.org\/10.1210\/jc.2013-1295 (2013).","DOI":"10.1210\/jc.2013-1295"},{"key":"26718_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","volume":"39","author":"G Bozdag","year":"2019","unstructured":"Bozdag, G., Mumusoglu, S., Coskun, Z. Y., Yarali, H. & Yildiz, B. O. Anti-M\u00fcllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population. Reprod. Biomed. Online. 39, 522\u2013529 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"26718_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould, A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J. Endocrinol. 192, 585\u2013594 (2007).","journal-title":"J. Endocrinol."},{"key":"26718_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000494901","volume":"53","author":"L Schiffer","year":"2019","unstructured":"Schiffer, L., Arlt, W. & O\u2019Reilly, M. W. Understanding the role of androgen action in female adipose tissue. Front. Horm. Res. 53, 33\u201349 (2019).","journal-title":"Front. Horm. Res."},{"key":"26718_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsbmb.2014.04.008","volume":"143","author":"MW O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly, M. W., House, P. J. & Tomlinson, J. W. Understanding androgen action in adipose tissue. J. Steroid Biochem. Mol. Biol. 143, 277\u2013284 (2014).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"26718_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo, E. et al. Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction. Gynecol. Endocrinol. 23, 700\u2013703 (2007).","journal-title":"Gynecol. Endocrinol."},{"key":"26718_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/BJ20130118","volume":"452","author":"MSC Wilson","year":"2013","unstructured":"Wilson, M. S. C., Livermore, T. M. & Saiardi, A. Inositol pyrophosphates: Between signalling and metabolism. Biochem. J. 452, 369\u2013379. https:\/\/doi.org\/10.1042\/BJ20130118 (2013).","journal-title":"Biochem. J."},{"key":"26718_CR29","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.1073\/pnas.90.13.5924","volume":"90","author":"I Asplin","year":"1993","unstructured":"Asplin, I., Galasko, G. & Larner, J. chiro-Inositol deficiency and insulin resistance: A comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. U S A. 90, 5924\u20135928 (1993).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"26718_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2741\/e695","volume":"6","author":"EK Barthelmess","year":"2014","unstructured":"Barthelmess, E. K. & Naz, R. K. Polycystic ovary syndrome: Current status and future perspective. Front. Biosci. (Elite Ed.) 6, 104\u2013119. https:\/\/doi.org\/10.2741\/e695 (2014).","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"26718_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.17772\/gp\/1705","volume":"85","author":"A Drosdzol-Cop","year":"2014","unstructured":"Drosdzol-Cop, A., Sidlo-Stawowy, A. & Sajdak, D. Skrzypulec-Plinta, V. Diagnosing polycystic ovary syndrome in adolescent girls. Ginekol. Pol. 85, 145\u2013148 (2014).","journal-title":"Ginekol. Pol."},{"key":"26718_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao, H., Zhang, J., Cheng, X., Nie, X. & He, B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J. Ovarian Res. 16, 1\u201317 (2023).","journal-title":"J. Ovarian Res."},{"key":"26718_CR33","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","volume":"71","author":"M Mongraw-Chaffin","year":"2018","unstructured":"Mongraw-Chaffin, M. et al. Metabolically healthy Obesity, transition to metabolic Syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 71, 1857\u20131865 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"26718_CR34","doi-asserted-by":"publisher","unstructured":"DeFronzo, R. A., Tobin, J. D. & Andres, R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237(3), E214\u2013E223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214 (1979).","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"26718_CR35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 22, 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"key":"26718_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"26718_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5114\/amsad.2019.84411","volume":"4","author":"Y Mirzaalian","year":"2019","unstructured":"Mirzaalian, Y. et al. The association of quantitative insulin sensitivity indices (HOMA-IR and QUICKI) with anthropometric and cardiometabolic indicators in adolescents. Archives Med. Sci. \u2013 Atherosclerotic Dis. 4, 32\u201337 (2019).","journal-title":"Archives Med. Sci. \u2013 Atherosclerotic Dis."},{"key":"26718_CR38","doi-asserted-by":"publisher","first-page":"1100547","DOI":"10.3389\/fmed.2023.1100547","volume":"10","author":"A Biernacka-Bartnik","year":"2023","unstructured":"Biernacka-Bartnik, A. et al. The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome. Front. Med. (Lausanne). 10, 1100547 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"26718_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.diabet.2008.02.001","volume":"34","author":"B Antuna-Puente","year":"2008","unstructured":"Antuna-Puente, B. et al. HOMA or QUICKI: is it useful to test the reproducibility of formulas? Diabetes Metab. 34, 294\u2013296 (2008).","journal-title":"Diabetes Metab."},{"key":"26718_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00125-023-06034-y","volume":"67","author":"A Petrelli","year":"2024","unstructured":"Petrelli, A. et al. HOMA-IR and the Matsuda index as predictors of progression to type 1 diabetes in autoantibody-positive relatives. Diabetologia 67, 290\u2013300 (2024).","journal-title":"Diabetologia"},{"key":"26718_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-47","volume":"13","author":"P Gayoso-Diz","year":"2013","unstructured":"Gayoso-Diz, P. et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr. Disord. 13, 1\u201310 (2013).","journal-title":"BMC Endocr. Disord"},{"key":"26718_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.diabres.2011.07.015","volume":"94","author":"P Gayoso-Diz","year":"2011","unstructured":"Gayoso-Diz, P. et al. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res. Clin. Pract. 94, 146\u2013155 (2011).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"26718_CR43","doi-asserted-by":"crossref","unstructured":"Carrillo-Larco, R. M. et al. The HOMA-IR performance to identify new diabetes cases by degree of urbanization and altitude in Peru: The CRONICAS cohort study. J Diabetes Res.\u00a02018\u00a0(2018).","DOI":"10.1155\/2018\/7434918"},{"key":"26718_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3346\/jkms.2006.21.4.695","volume":"21","author":"S Lee","year":"2006","unstructured":"Lee, S. et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean Non-diabetic adults. J. Korean Med. Sci. 21, 695 (2006).","journal-title":"J. Korean Med. Sci."},{"key":"26718_CR45","doi-asserted-by":"publisher","unstructured":"Ajmal, N., Khan, S. Z. & Shaikh, R. Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article.\u00a0Eur. J. Obstet. Gynecol. Reprod. Biol.:X.\u00a03\u00a0(2019). https:\/\/doi.org\/10.1016\/j.eurox.2019.100060","DOI":"10.1016\/j.eurox.2019.100060"},{"key":"26718_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva, D. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility 106, 6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003 (2016).","journal-title":"Fertility and Sterility"},{"key":"26718_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","volume":"293","author":"AS Jamil","year":"2016","unstructured":"Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G. & Al-Shawaf, T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch. Gynecol. Obstet. 293, 447\u2013456 (2016).","journal-title":"Arch. Gynecol. Obstet."},{"key":"26718_CR48","doi-asserted-by":"publisher","unstructured":"Kim, J. J. et al. Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome. Fertil. Steril. 101(5), 1424\u20131430. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.049 (2014).","DOI":"10.1016\/j.fertnstert.2014.01.049"},{"key":"26718_CR49","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva, D. et al. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertil. Steril. 106, 1510\u20131520e2 (2016).","journal-title":"Fertil. Steril."},{"key":"26718_CR50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.14310\/horm.2002.1593","volume":"14","author":"D Panidis","year":"2015","unstructured":"Panidis, D. et al. Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome. Hormones 14, 431\u2013437 (2015).","journal-title":"Hormones"},{"key":"26718_CR51","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.fertnstert.2008.02.161","volume":"91","author":"G Di Fede","year":"2009","unstructured":"Di Fede, G., Mansueto, P., Longo, R. A., Rini, G. B. & Carmina, E. Influence of Sociocultural factors on the ovulatory status of polycystic ovary syndrome. Fertil. Steril. 91, 1853\u20131856 (2009).","journal-title":"Fertil. Steril."},{"key":"26718_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1447-0756.2010.01478.x","volume":"37","author":"M Yilmaz","year":"2011","unstructured":"Yilmaz, M., Isaoglu, U., Delibas, I. B. & Kadanali, S. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J. Obstet. Gynecol. Res. 37, 1020\u20131026 (2011).","journal-title":"J. Obstet. Gynecol. Res."},{"key":"26718_CR53","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","volume":"116","author":"HY Zhang","year":"2009","unstructured":"Zhang, H. Y., Zhu, F. F., Xiong, J., Shi, X. B. & Fu, S. X. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 116, 1633\u20131639 (2009).","journal-title":"BJOG"},{"key":"26718_CR54","first-page":"252","volume":"5","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty, S., Naskar, T. K., Basu, B. R. & Vitamin, D. deficiency, insulin resistance, and antim\u00fcllerian hormone level: a Tale of trio in the expression of polycystic ovary syndrome. F S Sci. 5, 252\u2013264 (2024).","journal-title":"F S Sci."},{"key":"26718_CR55","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1467-789X.2011.00879.x","volume":"12","author":"S Czernichow","year":"2011","unstructured":"Czernichow, S., Kengne, A. P., Stamatakis, E., Hamer, M. & Batty, G. D. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual-participant meta-analysis of 82864 participants from nine cohort studies. Obes. Rev. 12, 680\u2013687 (2011).","journal-title":"Obes. Rev."},{"key":"26718_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygcen.2017.12.007","volume":"260","author":"NA Malini","year":"2018","unstructured":"Malini, N. A. Roy George, K. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) \u2013 Clinical based case control study. Gen. Comp. Endocrinol. 260, 51\u201357 (2018).","journal-title":"Gen. Comp. Endocrinol."},{"key":"26718_CR57","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/jog.14681","volume":"47","author":"L Wang","year":"2021","unstructured":"Wang, L. & Li, J. The value of serum-free androgen index in the diagnosis of polycystic ovary syndrome: A systematic review and meta-analysis. J. Obstet. Gynaecol. Res. 47, 1221\u20131231. https:\/\/doi.org\/10.1111\/jog.14681 (2021).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"26718_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijt.ijt_93_16","volume":"9","author":"R Aswini","year":"2017","unstructured":"Aswini, R. & Jayapalan, S. Modified Ferriman-Gallwey score in hirsutism and its association with metabolic syndrome. Int. J. Trichology. 9, 7\u201313 (2017).","journal-title":"Int. J. Trichology"},{"key":"26718_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpag.2010.06.003","volume":"24","author":"J Bronstein","year":"2011","unstructured":"Bronstein, J. et al. Age of onset of polycystic ovarian syndrome in girls May be earlier than previously thought. J. Pediatr. Adolesc. Gynecol. 24, 15\u201320 (2011).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"26718_CR60","first-page":"182","volume":"46","author":"A Indrayan","year":"2021","unstructured":"Indrayan, A. Medical biostatistics as a science of managing medical uncertainties. Indian J. Community Med. 46, 182\u2013185 (2021).","journal-title":"Indian J. Community Med."},{"key":"26718_CR61","first-page":"S230","volume":"23","author":"P Ranganathan","year":"2019","unstructured":"Ranganathan, P. & Pramesh, C. S. An introduction to statistics: Understanding hypothesis testing and statistical errors. Indian J. Crit. Care Med. 23, S230\u2013S231 (2019).","journal-title":"Indian J. Crit. Care Med."},{"key":"26718_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/569862","volume":"2012","author":"O Gluszak","year":"2012","unstructured":"Gluszak, O. et al. Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol. 2012, 1\u20137 (2012).","journal-title":"ISRN Endocrinol."},{"key":"26718_CR63","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4103\/ijem.IJEM_30_19","volume":"23","author":"G Sachdeva","year":"2019","unstructured":"Sachdeva, G., Gainder, S., Suri, V., Sachdeva, N. & Chopra, S. Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene. Indian J. Endocrinol. Metab. 23, 326 (2019).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"26718_CR64","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/09513590701536246","volume":"23","author":"B Pehlivanov","year":"2007","unstructured":"Pehlivanov, B. & Orbetzova, M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol. Endocrinol. 23, 604\u2013609 (2007).","journal-title":"Gynecol. Endocrinol."},{"key":"26718_CR65","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1210\/jc.2006-1327","volume":"91","author":"CK Welt","year":"2006","unstructured":"Welt, C. K. et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J. Clin. Endocrinol. Metab. 91, 4842\u20134848 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"26718_CR66","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1210\/jc.2006-1054","volume":"91","author":"D Dewailly","year":"2006","unstructured":"Dewailly, D., Catteau-Jonard, S., Reyss, A. C., Leroy, M. & Pigny, P. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J. Clin. Endocrinol. Metab. 91, 3922\u20133927 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"26718_CR67","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/genetics\/159.2.893","volume":"159","author":"J Wakeley","year":"2001","unstructured":"Wakeley, J. & Aliacar, N. Gene genealogies in a metapopulation. Genetics 159, 893\u2013905 (2001).","journal-title":"Genetics"},{"key":"26718_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5455\/medarh.2020.74.289-293","volume":"74","author":"Z Saadia","year":"2020","unstructured":"Saadia, Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. Non- obese women. Med. Arch. 74, 289\u2013293 (2020).","journal-title":"Med. Arch."},{"key":"26718_CR69","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly, D. et al. Definition and significance of polycystic ovarian morphology: A task force report from the androgen excess and polycystic ovary syndrome society. Hum. Reprod. Update. 20, 334\u2013352 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"26718_CR70","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"Li, H. et al. Free androgen index and Irisin in polycystic ovary syndrome. J. Endocrinol. Invest. 39, 549\u2013556 (2016).","journal-title":"J. Endocrinol. Invest."},{"key":"26718_CR71","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"SS Lim","year":"2019","unstructured":"Lim, S. S. et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obesity Reviews 20, 339\u2013352. https:\/\/doi.org\/10.1111\/obr.12762 (2019).","journal-title":"Obesity Reviews"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26718-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:09:12Z","timestamp":1764328152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26718"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26718-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42649"}}